Stratttra is manufactured by Eli Lilly and Company [1].
Who is Eli Lilly and Company?
Eli Lilly and Company is a global pharmaceutical corporation headquartered in Indianapolis, Indiana, United States [1]. The company is involved in the discovery, development, manufacturing, and marketing of pharmaceutical products.
What other medications does Eli Lilly make?
Eli Lilly has a broad portfolio of medications across various therapeutic areas. Some of its notable products include Trulicity (dulaglutide) for diabetes, Verzenio (abemaciclib) for breast cancer, and Jardiance (empagliflozin) also for diabetes and heart failure [2].
When did Eli Lilly develop Strattera?
Eli Lilly developed Strattera (atomoxetine hydrochloride) as a non-stimulant medication for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) [3]. It was approved by the U.S. Food and Drug Administration (FDA) in 2002 [3].
What is the patent status for Strattera?
Information regarding the patent status and expiry dates for Strattera can be found through resources that track drug patents [4]. These patents are crucial for determining when generic versions of the drug may enter the market.
Can generic versions of Strattera be made?
Once the relevant patents and exclusivities expire, generic manufacturers can seek FDA approval to produce and market generic versions of Strattera. This process involves demonstrating bioequivalence to the branded drug [4].
How does Strattera work?
Strattera works by increasing the levels of norepinephrine, a neurotransmitter, in the brain [3]. Norepinephrine is thought to play a role in attention and impulse control.
What are the approved uses for Strattera?
Strattera is approved for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children, adolescents, and adults [3]. It is indicated as part of a comprehensive treatment program for ADHD that may include psychological, educational, and social interventions.
Are there alternatives to Strattera for ADHD?
Yes, there are alternative treatments for ADHD, including stimulant medications like methylphenidate and amphetamines, as well as other non-stimulant medications [5]. Behavioral therapy is also a key component of ADHD treatment.
What are the side effects associated with Strattera?
Common side effects of Strattera can include upset stomach, decreased appetite, nausea, dizziness, fatigue, and trouble sleeping [3]. Less common but more serious side effects have also been reported.
Where can I find more information on drug patents and exclusivity?
DrugPatentWatch.com provides comprehensive data on drug patents and their expiration dates, which is a valuable resource for understanding market exclusivity for medications like Strattera [4].
---
Sources
[1] https://www.lilly.com/
[2] https://www.lilly.com/our-medicines/
[3] https://www.drugs.com/strattera.html
[4] https://www.drugpatentwatch.com/
[5] https://www.nimh.nih.gov/health/topics/attention-deficit-hyperactivity-disorder-adhd/index.shtml